
Erratum: Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells
Publication year - 2021
Publication title -
oncology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.267
H-Index - 57
eISSN - 1555-3906
pISSN - 0965-0407
DOI - 10.3727/096504021x16280937554409
Subject(s) - microrna , sorafenib , drug , apoptosis , ligand (biochemistry) , drug resistance , pd l1 , cancer research , chemistry , pharmacology , programmed cell death , microbiology and biotechnology , biology , gene , biochemistry , receptor , immunology , hepatocellular carcinoma , immune system , genetics , immunotherapy